EP0268640A4 - Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2. - Google Patents

Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2.

Info

Publication number
EP0268640A4
EP0268640A4 EP19870903575 EP87903575A EP0268640A4 EP 0268640 A4 EP0268640 A4 EP 0268640A4 EP 19870903575 EP19870903575 EP 19870903575 EP 87903575 A EP87903575 A EP 87903575A EP 0268640 A4 EP0268640 A4 EP 0268640A4
Authority
EP
European Patent Office
Prior art keywords
vaccine
stimulating
directed against
antibodies directed
enhancing production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870903575
Other languages
English (en)
French (fr)
Other versions
EP0268640A1 (de
Inventor
Philip O Livingston
Lloyd J Old
Michele Jones Calves
Edward J Natoli
Herbert F Oettgen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Publication of EP0268640A1 publication Critical patent/EP0268640A1/de
Publication of EP0268640A4 publication Critical patent/EP0268640A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001169—Tumor associated carbohydrates
    • A61K39/001171—Gangliosides, e.g. GM2, GD2 or GD3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP19870903575 1986-05-07 1987-05-07 Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2. Withdrawn EP0268640A4 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US86066386A 1986-05-07 1986-05-07
US860663 1986-05-07
US4480187A 1987-04-30 1987-04-30
US44801 1987-04-30

Publications (2)

Publication Number Publication Date
EP0268640A1 EP0268640A1 (de) 1988-06-01
EP0268640A4 true EP0268640A4 (de) 1989-11-30

Family

ID=26722007

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870903575 Withdrawn EP0268640A4 (de) 1986-05-07 1987-05-07 Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2.

Country Status (4)

Country Link
EP (1) EP0268640A4 (de)
JP (1) JPH01500119A (de)
AU (1) AU603585B2 (de)
WO (1) WO1987006840A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6805862B1 (en) 1989-05-25 2004-10-19 Sloan-Kattering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
ATE243713T1 (de) * 1989-05-25 2003-07-15 Sloan Kettering Inst Cancer Antiidiotypischer antikörper, der ein immunantwort gegen ein glykosphingolipid induziert und seine verwendung
US7585512B1 (en) 1990-05-08 2009-09-08 Thomas Jefferson University Composition and method of using tumor cells
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
US6149921A (en) * 1993-12-29 2000-11-21 Centro De Inmunologia Molecular Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment
BR9609026A (pt) * 1995-06-07 1999-07-06 Univ Jefferson Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines
EP1117432A1 (de) * 1998-10-01 2001-07-25 Progenics Pharmaceuticals, Inc. Kohlenhydrat-impfstoffe gegen virale erkrankungen
FR2790960B1 (fr) * 1999-03-15 2002-10-31 Pf Medicament Utilisation de fractions membranaires bacteriennes a activite immunostimulante dans le traitement de cancers, leurs procedes de preparation et les compositions pharmaceutiques les contenant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3135663A (en) * 1960-06-28 1964-06-02 Glaxo Group Ltd Vaccines
US3567585A (en) * 1963-07-12 1971-03-02 Ciba Geigy Corp Process for obtaining bcg-cultures
US4557931A (en) * 1982-12-02 1985-12-10 Regents Of The University Of California Antigenic compositions and methods for using same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *

Also Published As

Publication number Publication date
WO1987006840A1 (en) 1987-11-19
JPH01500119A (ja) 1989-01-19
AU7435887A (en) 1987-12-01
EP0268640A1 (de) 1988-06-01
AU603585B2 (en) 1990-11-22

Similar Documents

Publication Publication Date Title
NO872966L (no) Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
PT86318A (en) Process for the preparation of immunogenic proteins
OA08581A (en) Treatment of diseases caused by retroviruses.
LTIP1794A (en) Method for the production of an aids virus vaccine
EP0283505A4 (de) Impfstoff und verfahren zur herstellung.
AU2221688A (en) Method for stimulating the immune system
NO882388D0 (no) Fremgangsmaate til opparbeidelse av kontaminerte mineralstoffer.
EP0268640A4 (de) Impfstoff zur stimulierung oder erhöhung von antikörpern gegen gm2.
EP0246581A3 (en) Process for the preparation of alpha-substituted gamma-butyrolactones
EP0271834A3 (en) Process for the preparation of pyrimidines
AU1308288A (en) Method to stimulate the immune response to specific antigens
ZA872532B (en) Combined vaccine
ZW22487A1 (en) Vaccine
ZA876455B (en) Method for the preparation of anilinofumarate
EP0255904A3 (en) Process for the preparation of dihydrocyclocitral
EP0253183A3 (en) Process for the preparation of ticl4
EP0266401A4 (de) Impfstoffe.
AR242576A1 (es) Proceso para la preparacion de alfa-n-¡(hipoxantin-9-il)-pentiloxicarbonil¿-arginina.
FI871131A (fi) Menetelmä rokotteen valmistamiseksi
EP0294380A4 (de) Stimulierung von angiogenese.
IL79346A0 (en) Shiga vaccine
HUT43107A (en) Process for producing vaccine against melanome
ZA876597B (en) Process for the preparation of perhalohydrocarbon hypochlorites
EP0264089A3 (en) Process for the preparation of sulphatobetaines
EP0240741A3 (en) Process for the preparation of inulase

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19880510

A4 Supplementary search report drawn up and despatched

Effective date: 19891130

17Q First examination report despatched

Effective date: 19910730

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19920211

RIN1 Information on inventor provided before grant (corrected)

Inventor name: OLD, LLOYD, J.

Inventor name: CALVES, MICHELE, JONES

Inventor name: NATOLI, EDWARD, J.

Inventor name: LIVINGSTON, PHILIP, O.

Inventor name: OETTGEN, HERBERT, F.